Genes and immunity in worsening heart failure
Part of Heart & circulation clinical trials.
This study looks at how your genes and immune system affect heart failure. Researchers want to understand why some people have flare-ups (exacerbations) and how the body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic heart failure (with reduced or preserved pumping function) that has recently worsened
- Your heart condition is stable enough that you don't need IV medications to support your blood pressure
- You are not pregnant
- You have no recent heart attack, severe kidney failure, active infection, or cancer
- You are not taking medications that suppress your immune system (like for HIV or organ transplant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the biological causes of heart failure, including genes and other molecules, to better understand the disease. It may help researchers find new ways to treat heart failure in the future.
This study looks at how genes affect heart failure treatment response. It uses blood samples to find new markers that may help predict who will benefit most from therapy.
This study looks at whether changes in blood cells (called clonal hematopoiesis) are linked to heart failure. By testing your blood, researchers hope to learn more about how heart failure progresses and find new ways to treat it.
This study looks at blood markers and body composition in people hospitalized for heart failure with preserved or mildly reduced heart function. It aims to understand inflammation and fluid status better.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
This trial looks at patterns in your blood or heart-related “gene activity” (transcriptome) after heart procedures. It may help doctors understand why some people with heart failure or aortic valve narrowing (stenosis) do better than others.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.